Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Shares Outstanding (Diluted Average) (2017 - 2026)

Champions Oncology has reported Shares Outstanding (Diluted Average) over the past 14 years, most recently at $13.8 million for Q1 2026.

  • Quarterly results put Shares Outstanding (Diluted Average) at $13.8 million for Q1 2026, down 3.89% from a year ago — trailing twelve months through Jan 2026 was $13.8 million (down 3.89% YoY), and the annual figure for FY2025 was $14.3 million, up 5.31%.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $13.8 million at Champions Oncology, roughly flat from $13.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CSBR hit a ceiling of $14.4 million in Q1 2025 and a floor of $13.5 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $13.8 million (2025), compared with a mean of $13.8 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): dropped 4.87% in 2022 and later rose 5.67% in 2025.
  • Champions Oncology's Shares Outstanding (Diluted Average) stood at $13.5 million in 2022, then fell by 0.18% to $13.5 million in 2023, then increased by 3.85% to $14.0 million in 2024, then dropped by 1.84% to $13.8 million in 2025, then grew by 0.34% to $13.8 million in 2026.
  • The last three reported values for Shares Outstanding (Diluted Average) were $13.8 million (Q1 2026), $13.8 million (Q4 2025), and $13.8 million (Q3 2025) per Business Quant data.